Global Bioinformatics in IVD Testing Market Research Report 2023

Publication ID:

PB502232433

Publication Date:

February 6, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Bioinformatics is a multidisciplinary research field that combines computer science, biology, statistics and mathematics for the management of biological information.
Highlights
The global Bioinformatics in IVD Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America holds the largest market share in this market presently due to the increase in health awareness and rise in patient expenditure. Asia-Pacific is expected to capture the market in the forecast period due to the rising prevalence of cancer and other rare diseases.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bioinformatics in IVD Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioinformatics in IVD Testing.
The Bioinformatics in IVD Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bioinformatics in IVD Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioinformatics in IVD Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Affymetrix
AssureRx Health Inc.
Aperico Technologies Inc.
Biodesix Inc.
Bioreference Laboratories Inc.
CardioDx Inc.
Datech Oncology
Life Technologies, Pathogenica
Medtronic Inc.
Signal genetics
One Lambda Inc.
Segment by Type
Hardware
Software
Segment by Application
Cardiovascular Diseases
Chronic Diseases
Diabetes
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioinformatics in IVD Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bioinformatics in IVD Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Hardware
1.2.3 Software
1.3 Market by Application
1.3.1 Global Bioinformatics in IVD Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cardiovascular Diseases
1.3.3 Chronic Diseases
1.3.4 Diabetes
1.3.5 Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioinformatics in IVD Testing Market Perspective (2018-2029)
2.2 Bioinformatics in IVD Testing Growth Trends by Region
2.2.1 Global Bioinformatics in IVD Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Bioinformatics in IVD Testing Historic Market Size by Region (2018-2023)
2.2.3 Bioinformatics in IVD Testing Forecasted Market Size by Region (2024-2029)
2.3 Bioinformatics in IVD Testing Market Dynamics
2.3.1 Bioinformatics in IVD Testing Industry Trends
2.3.2 Bioinformatics in IVD Testing Market Drivers
2.3.3 Bioinformatics in IVD Testing Market Challenges
2.3.4 Bioinformatics in IVD Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioinformatics in IVD Testing Players by Revenue
3.1.1 Global Top Bioinformatics in IVD Testing Players by Revenue (2018-2023)
3.1.2 Global Bioinformatics in IVD Testing Revenue Market Share by Players (2018-2023)
3.2 Global Bioinformatics in IVD Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bioinformatics in IVD Testing Revenue
3.4 Global Bioinformatics in IVD Testing Market Concentration Ratio
3.4.1 Global Bioinformatics in IVD Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioinformatics in IVD Testing Revenue in 2022
3.5 Bioinformatics in IVD Testing Key Players Head office and Area Served
3.6 Key Players Bioinformatics in IVD Testing Product Solution and Service
3.7 Date of Enter into Bioinformatics in IVD Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioinformatics in IVD Testing Breakdown Data by Type
4.1 Global Bioinformatics in IVD Testing Historic Market Size by Type (2018-2023)
4.2 Global Bioinformatics in IVD Testing Forecasted Market Size by Type (2024-2029)
5 Bioinformatics in IVD Testing Breakdown Data by Application
5.1 Global Bioinformatics in IVD Testing Historic Market Size by Application (2018-2023)
5.2 Global Bioinformatics in IVD Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Bioinformatics in IVD Testing Market Size (2018-2029)
6.2 North America Bioinformatics in IVD Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Bioinformatics in IVD Testing Market Size by Country (2018-2023)
6.4 North America Bioinformatics in IVD Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bioinformatics in IVD Testing Market Size (2018-2029)
7.2 Europe Bioinformatics in IVD Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Bioinformatics in IVD Testing Market Size by Country (2018-2023)
7.4 Europe Bioinformatics in IVD Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bioinformatics in IVD Testing Market Size (2018-2029)
8.2 Asia-Pacific Bioinformatics in IVD Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Bioinformatics in IVD Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Bioinformatics in IVD Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bioinformatics in IVD Testing Market Size (2018-2029)
9.2 Latin America Bioinformatics in IVD Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Bioinformatics in IVD Testing Market Size by Country (2018-2023)
9.4 Latin America Bioinformatics in IVD Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bioinformatics in IVD Testing Market Size (2018-2029)
10.2 Middle East & Africa Bioinformatics in IVD Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Bioinformatics in IVD Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Bioinformatics in IVD Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Affymetrix
11.1.1 Affymetrix Company Detail
11.1.2 Affymetrix Business Overview
11.1.3 Affymetrix Bioinformatics in IVD Testing Introduction
11.1.4 Affymetrix Revenue in Bioinformatics in IVD Testing Business (2018-2023)
11.1.5 Affymetrix Recent Development
11.2 AssureRx Health Inc.
11.2.1 AssureRx Health Inc. Company Detail
11.2.2 AssureRx Health Inc. Business Overview
11.2.3 AssureRx Health Inc. Bioinformatics in IVD Testing Introduction
11.2.4 AssureRx Health Inc. Revenue in Bioinformatics in IVD Testing Business (2018-2023)
11.2.5 AssureRx Health Inc. Recent Development
11.3 Aperico Technologies Inc.
11.3.1 Aperico Technologies Inc. Company Detail
11.3.2 Aperico Technologies Inc. Business Overview
11.3.3 Aperico Technologies Inc. Bioinformatics in IVD Testing Introduction
11.3.4 Aperico Technologies Inc. Revenue in Bioinformatics in IVD Testing Business (2018-2023)
11.3.5 Aperico Technologies Inc. Recent Development
11.4 Biodesix Inc.
11.4.1 Biodesix Inc. Company Detail
11.4.2 Biodesix Inc. Business Overview
11.4.3 Biodesix Inc. Bioinformatics in IVD Testing Introduction
11.4.4 Biodesix Inc. Revenue in Bioinformatics in IVD Testing Business (2018-2023)
11.4.5 Biodesix Inc. Recent Development
11.5 Bioreference Laboratories Inc.
11.5.1 Bioreference Laboratories Inc. Company Detail
11.5.2 Bioreference Laboratories Inc. Business Overview
11.5.3 Bioreference Laboratories Inc. Bioinformatics in IVD Testing Introduction
11.5.4 Bioreference Laboratories Inc. Revenue in Bioinformatics in IVD Testing Business (2018-2023)
11.5.5 Bioreference Laboratories Inc. Recent Development
11.6 CardioDx Inc.
11.6.1 CardioDx Inc. Company Detail
11.6.2 CardioDx Inc. Business Overview
11.6.3 CardioDx Inc. Bioinformatics in IVD Testing Introduction
11.6.4 CardioDx Inc. Revenue in Bioinformatics in IVD Testing Business (2018-2023)
11.6.5 CardioDx Inc. Recent Development
11.7 Datech Oncology
11.7.1 Datech Oncology Company Detail
11.7.2 Datech Oncology Business Overview
11.7.3 Datech Oncology Bioinformatics in IVD Testing Introduction
11.7.4 Datech Oncology Revenue in Bioinformatics in IVD Testing Business (2018-2023)
11.7.5 Datech Oncology Recent Development
11.8 Life Technologies, Pathogenica
11.8.1 Life Technologies, Pathogenica Company Detail
11.8.2 Life Technologies, Pathogenica Business Overview
11.8.3 Life Technologies, Pathogenica Bioinformatics in IVD Testing Introduction
11.8.4 Life Technologies, Pathogenica Revenue in Bioinformatics in IVD Testing Business (2018-2023)
11.8.5 Life Technologies, Pathogenica Recent Development
11.9 Medtronic Inc.
11.9.1 Medtronic Inc. Company Detail
11.9.2 Medtronic Inc. Business Overview
11.9.3 Medtronic Inc. Bioinformatics in IVD Testing Introduction
11.9.4 Medtronic Inc. Revenue in Bioinformatics in IVD Testing Business (2018-2023)
11.9.5 Medtronic Inc. Recent Development
11.10 Signal genetics
11.10.1 Signal genetics Company Detail
11.10.2 Signal genetics Business Overview
11.10.3 Signal genetics Bioinformatics in IVD Testing Introduction
11.10.4 Signal genetics Revenue in Bioinformatics in IVD Testing Business (2018-2023)
11.10.5 Signal genetics Recent Development
11.11 One Lambda Inc.
11.11.1 One Lambda Inc. Company Detail
11.11.2 One Lambda Inc. Business Overview
11.11.3 One Lambda Inc. Bioinformatics in IVD Testing Introduction
11.11.4 One Lambda Inc. Revenue in Bioinformatics in IVD Testing Business (2018-2023)
11.11.5 One Lambda Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Affymetrix
AssureRx Health Inc.
Aperico Technologies Inc.
Biodesix Inc.
Bioreference Laboratories Inc.
CardioDx Inc.
Datech Oncology
Life Technologies, Pathogenica
Medtronic Inc.
Signal genetics
One Lambda Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂